22-42808824-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_014570.5(ARFGAP3):āc.1263T>Gā(p.Phe421Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,502 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_014570.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARFGAP3 | NM_014570.5 | c.1263T>G | p.Phe421Leu | missense_variant | 13/16 | ENST00000263245.10 | NP_055385.3 | |
ARFGAP3 | NM_001142293.2 | c.1131T>G | p.Phe377Leu | missense_variant | 12/15 | NP_001135765.1 | ||
ARFGAP3 | XM_005261525.5 | c.1131T>G | p.Phe377Leu | missense_variant | 12/15 | XP_005261582.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARFGAP3 | ENST00000263245.10 | c.1263T>G | p.Phe421Leu | missense_variant | 13/16 | 1 | NM_014570.5 | ENSP00000263245.5 | ||
ARFGAP3 | ENST00000437119.6 | c.1131T>G | p.Phe377Leu | missense_variant | 12/15 | 1 | ENSP00000388791.2 | |||
ARFGAP3 | ENST00000453516.5 | c.669T>G | p.Phe223Leu | missense_variant | 7/8 | 3 | ENSP00000403995.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251206Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135758
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461502Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 727032
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2024 | The c.1263T>G (p.F421L) alteration is located in exon 13 (coding exon 13) of the ARFGAP3 gene. This alteration results from a T to G substitution at nucleotide position 1263, causing the phenylalanine (F) at amino acid position 421 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at